Cantor Fitzgerald Cuts Core Scientific (NASDAQ:CORZ) Price Target to $25.00

Core Scientific (NASDAQ:CORZ) had its price objective decreased by Cantor Fitzgerald from $26.00 to $25.00 in a research note published on Tuesday morning,Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock.

A number of other research analysts have also issued reports on CORZ. Citigroup raised Core Scientific from a “market perform” rating to an “outperform” rating in a report on Thursday, December 18th. Keefe, Bruyette & Woods lifted their price objective on shares of Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a research note on Tuesday, January 27th. Sanford C. Bernstein boosted their target price on shares of Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. BTIG Research raised shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 target price for the company in a research note on Tuesday, January 6th. Finally, Citizens Jmp upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target on the stock in a research report on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Core Scientific has a consensus rating of “Moderate Buy” and an average target price of $24.84.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $16.00 on Tuesday. The stock has a market cap of $5.05 billion, a price-to-earnings ratio of 13.68 and a beta of 6.87. Core Scientific has a 12 month low of $6.20 and a 12 month high of $23.63. The stock’s 50 day moving average price is $17.28 and its 200 day moving average price is $16.95.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Monday, March 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. During the same quarter last year, the business posted ($0.69) earnings per share. The firm’s revenue for the quarter was down 16.0% compared to the same quarter last year. On average, sell-side analysts expect that Core Scientific will post 0.52 EPS for the current year.

Institutional Trading of Core Scientific

Several hedge funds and other institutional investors have recently modified their holdings of the business. Allworth Financial LP grew its holdings in shares of Core Scientific by 206.5% during the third quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after buying an additional 950 shares in the last quarter. Larson Financial Group LLC boosted its position in Core Scientific by 936.7% during the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after acquiring an additional 1,686 shares during the period. HHM Wealth Advisors LLC boosted its position in Core Scientific by 96.5% during the 2nd quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock worth $33,000 after acquiring an additional 946 shares during the period. Osaic Holdings Inc. grew its stake in Core Scientific by 112.1% during the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after acquiring an additional 1,066 shares in the last quarter. Finally, Danske Bank A S acquired a new position in shares of Core Scientific in the 4th quarter valued at about $36,000.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
• Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
• Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
• Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
• Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
• Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
• Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.